Skip to main content
FinSpry Logo
FinSpry
NRIX logo
NRIX
(NASDAQ)
Nurix Therapeutics, Inc.
$16.42-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Nurix Therapeutics (NRIX) Stock Price & Financial Analysis

Nurix Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$15.50 - $16.50
52-Week High$22.50
52-Week Low$8.20
Open$15.91
Volume2.19M
Average Volume (3M)977.61K
Market Cap1.68B
Shares Outstanding110.07M
Price to Sales (P/S)23.37
Price to Book (P/B)3.49
EV/EBITDA-5.61
Revenue (TTM)71.78M
Net Income (TTM)-295.28M
Free Cash Flow (TTM)-271.85M
EPS (TTM)$-3.16
Profit Margin-411.37%
Operating Margin-439.26%
Return on Equity (ROE)-61.40%
Debt to Equity0.12
50-Day MA$15.95
200-Day MA$14.27
52-Week Change59.92%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Nurix Therapeutics

What is the current stock price for NRIX?

As of the latest trading session, NRIX stock trades at $15.51. The 52-week range is $8.20–$22.50, with a day range of $15.50–$16.50.

What is the P/E ratio for NRIX?

The P/E ratio (Price-to-Earnings) for NRIX is shown in the Key Statistics section. This valuation metric helps compare Nurix Therapeutics, Inc. to industry peers.

Does NRIX pay dividends?

Nurix Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NRIX?

Based on 3 analysts, the consensus for NRIX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of NRIX?

Nurix Therapeutics's market capitalization is $1.71B, classifying it as a small-cap company. Nurix Therapeutics operates in the Healthcare sector within the Biotechnology industry.